Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026)
Trevi Therapeutics' quarterly Prepaid Assets came in at $2.2 million in Q1 2026, up 44.84% year-on-year from $1.5 million in Q1 2025, and up 3.89% quarter-over-quarter from $2.1 million in Q4 2025.
Trevi Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 44.84% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 44.84% YoY), and the FY2025 full-year result was $2.1 million, up 127.16% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $4.0 million in Q3 2023, with the low at $382000.0 in Q2 2022.
- Average Prepaid Assets over 5 years is $1.6 million, with a median of $1.3 million recorded in 2023.
- Year-over-year, Prepaid Assets plunged 81.41% in 2022 and soared 859.38% in 2023.
- Tracing TRVI's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then decreased by 27.15% to $955000.0 in 2023, then retreated by 1.68% to $939000.0 in 2024, then jumped by 127.16% to $2.1 million in 2025, then increased by 3.89% to $2.2 million in 2026.
- The last three Prepaid Assets figures came in at $2.2 million (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 830,000.00 |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 955,000.00 |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 421,000.00 |
| Jun 30, 2022 | 382,000.00 |
| Mar 31, 2022 | 477,000.00 |
| Dec 31, 2021 | 241,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 2.06 Mn |
| Mar 31, 2021 | 589,000.00 |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.86 Mn |
| Jun 30, 2020 | 149,000.00 |
| Mar 31, 2020 | 134,000.00 |
| Dec 31, 2019 | 77,000.00 |
| Sep 30, 2019 | 66,000.00 |
| Jun 30, 2019 | 27,000.00 |
| Mar 31, 2019 | 1.67 Mn |
| Dec 31, 2018 | 1.44 Mn |